Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_assertion type Assertion NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_head.
- NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_assertion description "[Our findings suggest that the CYP2D6*5 allele is likely to affect vulnerability to development of neuroleptic malignant syndrome ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_provenance.
- NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_assertion evidence source_evidence_literature NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_provenance.
- NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_assertion SIO_000772 17701031 NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_provenance.
- NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_assertion wasDerivedFrom lhgdn-20090331 NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_provenance.
- NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_assertion wasGeneratedBy ECO_0000203 NP228274.RAILhMgfBydMZGRUWz2_dDT66OWnuS24i4AS_IEnL9e9k130_provenance.